approval
saveARBLI (LOSARTAN POTASSIUM) — FDA approval
community read0 votes
Sponsor: SCIENTURE. Form: SUSPENSION. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalLOSARTAN POTASSIUM — FDA approvalApr 10, 2026 · 175d ago
- approvalARBLI (LOSARTAN POTASSIUM) — FDA approvalFeb 18, 2026 · 226d ago
- approvalLOSARTAN POTASSIUM — FDA approvalJan 16, 2026 · 259d ago
- approvalLOSARTAN POTASSIUM — FDA approvalDec 16, 2025 · 290d ago
- approvalLOSARTAN POTASSIUM — FDA approvalOct 29, 2025 · 338d ago
- approvalLOSARTAN POTASSIUM — FDA approvalAug 23, 2023 · 1136d ago
- approvalLOSARTAN POTASSIUM — FDA approvalFeb 23, 2023 · 1317d ago
- approvalLOSARTAN POTASSIUM — FDA approvalSep 16, 2022 · 1477d ago
🐶 often sniffed alongside
top 8- tagApproval238 co-mentions · 119 sources
- drugALDACTAZIDE156 co-mentions · 78 sources
- drugARBLI121 co-mentions · 119 sources
- tagSmall Molecule119 co-mentions · 119 sources
- drugLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE78 co-mentions · 78 sources
- companyAurobindo Pharma Ltd15 co-mentions · 15 sources
- companyLupin Ltd14 co-mentions · 14 sources
- companyMicro Labs Ltd9 co-mentions · 9 sources
comments(0)
5-min edit window · permanent after that